Merck-Pfizer Avelumab gets FDA Breakthrough Therapy Status

19.11.2015 - A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...